L-Arginine 500 mg & L-Ornithine 250 mg
L-Arginine 500 mg & L-Ornithine 250 mg, NPN 80038067: natural health product licensed in Canada. Medicinal ingredients: Acide (S)-2,5-diaminopentanoïque.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide (S)-2,5-diaminopentanoïque | 250 mg | Not calculated |
Non-medicinal ingredients
L-leucine, Hydroxypropyl methylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
L-arginine supports protein/creatine synthesis and nitric oxide production. In combination with L-ornithine, L-arginine supports detoxification of ammonia in the body and support and maintain nitrogen balance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contra-Indications
Do not take if you are breastfeeding, if you suffer from diabetes, impaired renal function, herpes infection, high allergic tendencies, or if you have previously had a heart attack.
- Known Adverse Reactions
May cause flushing and other dermal side effects, nausea and vomiting, abdominal cramps and bloating. Some people may experience gastrointestinal discomfort (such as diarrhea).
- Cautions and Warnings
Consult a health care practitioner prior to use if you are pregnant, if you have renal/kidney disease or if you are following a low protein diet, if you suffer from a cardiovascular disease and are attempting an increase in physical activity or if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners. Consult a health care practitioner if your cardiovascular condition worsens.
Product record
- Licence holder
- Les Entreprises Gamma Force Inc.
- NPN or DIN-HM
- 80038067
- Status
- Inactive licence
- Licence date
- 4 December 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80038067
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “L-Arginine 500 mg & L-Ornithine 250 mg (Les Entreprises Gamma Force Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80038067-l-arginine-500-mg-l-ornithine-250-mg, updated 4 December 2012.